EHA 2021

Lymphoma

Immuno-oncology agents are effective in treating classic Hodgkin’s lymphoma

Presented By

Dr Marc André, Centre Hospitalier Universitaire UCL Namur, Belgium

Trial

CheckMate 205; KEYNOTE-087

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 12:26

MATRix with ASCT: best long-term survival for primary CNS lymphoma

Presented By

Dr Gerald Illerhaus, Klinikum der Landeshauptstadt Stuttgart, Germany

Trial

Phase 2, IELSG32

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 12:05

Naratuximab emtansine + rituximab safe and effective in diffuse large B-cell lymphoma

Presented By

Dr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, USA

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 11:55

The journey ahead for CAR T-cell therapy in r/r follicular lymphoma

Presented By

Dr Bastian von Tresckow, University Hospital Essen, Germany

Trial

ZUMA-5; ELARA

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 11:47

ZUMA-5 vs SCHOLAR-5: Axicabtagene ciloleucel significantly improves FL outcome

Presented By

Prof. John Gribben, Barts Cancer Institute, UK

Trial

ZUMA-5; SCHOLAR-5

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 11:18

Promising chemo-free treatment options in r/r DLBCL

Presented By

Prof. Marco Ladetto, University del Piemonte Orientale, Italy

Trial

LOTIS-2

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 11:17

Leukaemia

Sabatolimab achieved durable responses in patients with high-risk MDS and AML

Presented By

Prof. Andrew Wei, Alfred Hospital and Monash University, Australia

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:27

Final analysis of EURO-SKI: primary endpoints met in chronic myeloid leukaemia

Presented By

Prof. Susanne Saußele, Heidelberg University, Germany

Trial

EURO-SKI

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:13

Favourable outcomes with zanubrutinib versus ibrutinib in patients with r/r CLL

Presented By

Prof. Peter Hillmen, University of Leeds, UK

Trial

Phase 3, ALPINE

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:08

Oral azacitidine improves overall survival in patients with acute myeloid leukaemia

Presented By

Prof. Hartmut Döhner, Universitätsklinikum Ulm, Germany

Trial

Phase 2, QUAZAR AML-001

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:59

Reduced-intensity conditioning ASCT is effective in older patients with AML

Presented By

Prof. Nigel Russell, Guy's Hospital, UK

Trial

AML16; AML18

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:55

ELEVATE-TN: Acalabrutinib shows long-term efficacy in chronic lymphocytic leukaemia

Presented By

Dr Jeff Sharman, US Oncology Network, USA

Trial

Phase 3, ELEVATE-TN

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:50

ELEVATE-RR: Acalabrutinib demonstrates similar efficacy and better safety versus ibrutinib

Presented By

Prof. Peter Hillmen, St James’s University Hospital, UK

Trial

Phase 3, ELEVATE-RR

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:43

Fixed 12 cycles and MRD-guided venetoclax consolidation effective in CLL

Presented By

Dr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands

Trial

Phase 2, HOVON 139/GiVe

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:38

GLOW: Ibrutinib + venetoclax showed superior PFS as first-line CLL treatment

Presented By

Prof. Arnon Kater, Amsterdam University Medical Centres, the Netherlands

Trial

Phase 2, GLOW

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 13:33

Myeloma and Myelofibrosis

Novel targets in myelofibrosis: overview of emergent therapies

Presented By

Prof. Francesco Passamonti, University of Insubria, Italy

Trial

PERSIST; SIMPLIFY; BOREAS

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:54

Immune therapy of multiple myeloma

Presented By

Prof. Noopur Raje, Massachusetts General Cancer Center, USA

Trial

KarMMA; CARTITUDE-1; UNIVERSAL

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:49

MAIA results confirm superior efficacy of daratumumab with standard-of-care

Presented By

Prof. Thierry Facon, University of Lille, France

Trial

Phase 3, MAIA

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:46

ANDROMEDA: Addition of daratumumab showed superior efficacy in patients with AL amyloidosis

Presented By

Prof. Efstathios Kastritis, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, ANDROMEDA

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:31

Thrombotic and Thrombocytopenic Disorders including COVID-19 related

Acquired TTP: new treatments and updated guidelines

Presented By

Dr María Mingot-Castellano, Hospital Universitario Virgen del Rocío, Spain

Trial

HERCULES; TITAN

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:25

Maternal screening to prevent foetal and neonatal alloimmune thrombocytopenia

Presented By

Prof. Dick Oepkes, Leiden University Medical Centre, the Netherlands

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:21

Fostamatinib effectively increased platelet counts in immune thrombocytopenic purpura

Presented By

Prof. Waleed Ghanima, University of Oslo, Norway

Trial

Phase 3, FIT-1,-2,-3

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:16

Physiopathology of coagulopathy in haematological malignancies and COVID-19

Presented By

Prof. Marcel Levi, Amsterdam University Medical Centre, the Netherlands

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:11

Haemostatic abnormalities are associated with mortality in COVID-19

Presented By

Dr Yu Hu, Wuhan Union Hospital, China

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:07

Mechanisms of COVID-19 vaccine-induced thrombotic thrombocytopenia

Presented By

Prof. Andreas Greinacher, Universitätsmedizin Greifswald, Germany

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 15:03

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: discovery and diagnosis

Presented By

Prof. Sabine Eichinger, Medical University Hospital of Vienna, Austria

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:58

Haemoglobinopathies